Scientists probe immune clues to boost cancer therapy success
NCT ID NCT07180992
Summary
This study aims to understand why some patients with multiple myeloma respond better to CAR-T cell therapy than others. Researchers will analyze a specific type of immune cell, called a monocyte, in about 25 patients before and after they receive CAR-T treatment. The goal is to find markers that can predict treatment success and help improve future care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU Amiens
RECRUITINGAmiens, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.